1. Selective p300 inhibitor C646 inhibited HPV E6-E7 genes, altered glucose metabolism and induced apoptosis in cervical cancer cells
   Hongpeng He et al, 2017, European Journal of Pharmacology CrossRef
2. Transcription factors-Intricate players of the bone morphogenetic protein signaling pathway
   M. Ampuja et al, 2018, Genes Chromosomes Cancer CrossRef
3. Identification of key genes and transcription factors in aging mesenchymal stem cells by DNA microarray data
   Yang'ou Wu et al, 2019, Gene CrossRef
4. The role of HIF-1α, CBP and p300 in the regulation of Nav1.5 expression in breast cancer cells
   Hemaniswarri Dewi Dewadas et al, 2019, Gene Reports CrossRef
5. Role of p300 in the pathogenesis of Henoch-Schonlein purpura nephritis and as a new target of glucocorticoid therapy in mice
   Ming-Yu Jiang et al, 2019, Chinese Medical Journal CrossRef
6. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes
   Mohamad Akbari et al, 2019, Inflammopharmacol CrossRef
7. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
   Cristian Scheau et al, 2019, Anal Cell Pathol (Amst) CrossRef
8. Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression
   Junhui Xue et al, 2019, Cancer Letters CrossRef
9. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
   Yuan Cheng et al, 2019, Sig Transduct Target Ther CrossRef
10. Prognostic role of upregulated P300 expression in human cancers: A clinical study of synovial sarcoma and a meta‑analysis
    Zihan Liu et al, 2019, Exp Ther Med CrossRef
11. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway
    Changwei Dou et al, 2020, Cell Death Dis CrossRef
12. Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
    Qianwei Zhao et al, 2020, Front. Genet. CrossRef
13. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells
    Weiwei Tao et al, 2020, EMBO Mol Med CrossRef
14. Effects of the histone acetylase inhibitor C646 on growth and differentiation of adipose-derived stem cells
    Zhimin Wang et al, 2021, Cell Cycle CrossRef
15. Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism
    Ling-Yan Cai et al, 2021, Cancer Res CrossRef
16. Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models
    Marina Galicia-Moreno et al, 2021, Canadian Journal of Gastroenterology and Hepatology CrossRef
17. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma
    Sangjoon Choi et al, 2021, J Cancer Res Clin Oncol CrossRef
18. null
    D. Chen et al, 2021 CrossRef
19. Sensitive and specific detection of micrometastasis of hepatic carcinoma in peripheral blood by immunomagnetic nanobeads polymerase chain reaction
    Linping Dong et al, 2021, mat express CrossRef
20. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma
    Yanan Jiang et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
21. The β-catenin/CBP signaling axis participates in sepsis-induced inflammatory lung injury
    Xia Cheng et al, 2022, Exp Biol Med (Maywood) CrossRef
22. An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resection
    Ye Jin et al, 2022, Future Oncology CrossRef
23. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance
    Yu-Chin Liu et al, 2022, Clin Epigenet CrossRef
24. 3D chromatin remodeling potentiates transcriptional programs driving cell invasion
    Benjamin Lebeau et al, 2022, Proc. Natl. Acad. Sci. U.S.A. CrossRef
25. Bromodomain (BrD) Family Members as Regulators of Cancer Stemness—A Comprehensive Review
    Patrycja Czerwinska et al, 2023, IJMS CrossRef
26. Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer
    Ruizhi Lai et al, 2024, European Journal of Medicinal Chemistry CrossRef
27. Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
    Qi Chang et al, 2024, J. Med. Chem. CrossRef
28. Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation
    Demond Williams et al, 2024, IJMS CrossRef